Michael Gelband’s Caesarstone CSTE Stock Holding History

Michael Gelband’s Portfolio CSTE Stock Details CSTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-23,476	Closed	-$266K	–	2271
2021 Q4	$266K	Buy	+23,476	New	+$281K	﹤0.01%	1709

Other funds holding CSTE

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Michael Gelband's CSTE Position: Q1 2022 in Review

Michael Gelband sold out of Caesarstone (CSTE) in Q1 2022, closing a stake of 23,476 shares — an estimated $266K sold.

Michael Gelband first reported a position in CSTE in Q4 2021 and held it in 1 quarter. The position peaked at $266K in Q4 2021. 96 funds tracked by Wall St. Rank hold CSTE as of Q1 2022.

Michael Gelband reported no remaining Caesarstone position as of Q1 2022 after selling out during the quarter.
Michael Gelband sold 23,476 Caesarstone shares in Q1 2022, an estimated $266K.
Michael Gelband first reported a position in Caesarstone in Q4 2021 and held it in 1 quarter.
Michael Gelband's Caesarstone position peaked at $266K in Q4 2021.
96 funds tracked by Wall St. Rank held Caesarstone as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.